Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLCO
3726
DELISTED
Cool Company
CLCO
| $5.95M | ﹤0.01% |
535,303
-396,973
| -43% | -$4.6M |
|
|
XRN
3727
Chiron Real Estate Inc
XRN
$477M
| $5.95M | ﹤0.01% |
135,918
-108,794
| -44% | -$5.22M |
|
|
ETJ
3728
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$575M
| $5.95M | ﹤0.01% |
712,074
-713,732
| -50% | -$5.83M |
|
3729
Liberty Broadband Class A
LBRDA
$5.16B
| $5.94M | ﹤0.01% |
104,042
-85,226
| -45% | -$5.62M |
|
|
RVNC
3730
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.92M | ﹤0.01% |
1,203,904
-554,594
| -32% | -$3.28M |
|
3731
Zeta Global
ZETA
$6.69B
| $5.92M | ﹤0.01% |
541,608
-1,044,498
| -66% | -$10.4M |
|
3732
Nuveen Select Tax-Free Income Portfolio
NXP
$900M
| $5.92M | ﹤0.01% |
409,644
-429,686
| -51% | -$6.27M |
|
|
DHF
3733
BNY Mellon High Yield Strategies Fund
DHF
$172M
| $5.91M | ﹤0.01% |
2,442,178
-2,392,886
| -49% | -$5.6M |
|
3734
Paymentus
PAY
$4.86B
| $5.91M | ﹤0.01% |
259,783
-117,863
| -31% | -$2.13M |
|
3735
TTEC Holdings
TTEC
$124M
| $5.89M | ﹤0.01% |
568,251
-489,967
| -46% | -$8.21M |
|
3736
York Water
YORW
$514M
| $5.89M | ﹤0.01% |
162,275
-350,897
| -68% | -$12.7M |
|
3737
Amylyx Pharmaceuticals
AMLX
$2.54B
| $5.88M | ﹤0.01% |
2,070,653
-3,589,833
| -63% | -$47M |
|
3738
UroGen Pharma
URGN
$2.29B
| $5.86M | ﹤0.01% |
390,549
-519,699
| -57% | -$8.49M |
|
3739
Ennis
EBF
$564M
| $5.85M | ﹤0.01% |
285,120
-195,128
| -41% | -$3.98M |
|
3740
Thryv Holdings
THRY
$108M
| $5.85M | ﹤0.01% |
263,051
-310,513
| -54% | -$6.43M |
|
3741
Wave Life Sciences
WVE
$1.2B
| $5.83M | ﹤0.01% |
945,120
+564,464
| +148% | +$2.83M |
|
3742
BlackRock MuniHoldings Fund
MHD
$606M
| $5.83M | ﹤0.01% |
482,346
-364,978
| -43% | -$4.36M |
|
3743
Capital Group Global Growth Equity ETF
CGGO
$11.8B
| $5.82M | ﹤0.01% |
202,201
+191,833
| +1,850% | +$5.22M |
|
3744
Delek Logistics
DKL
$3.02B
| $5.8M | ﹤0.01% |
141,608
+31,252
| +28% | +$1.37M |
|
3745
Amneal Pharmaceuticals
AMRX
$5.79B
| $5.79M | ﹤0.01% |
955,962
+71,376
| +8% | +$402K |
|
3746
JPMorgan International Bond Opportunities ETF
JPIB
$2.12B
| $5.79M | ﹤0.01% |
121,494
+43,064
| +55% | +$2.05M |
|
3747
Vitesse Energy
VTS
$665M
| $5.78M | ﹤0.01% |
243,544
-323,508
| -57% | -$7.1M |
|
3748
CEVA Inc
CEVA
$1.08B
| $5.77M | ﹤0.01% |
254,129
-386,209
| -60% | -$8.44M |
|
3749
Malibu Boats
MBUU
$567M
| $5.76M | ﹤0.01% |
133,093
-135,727
| -50% | -$6.22M |
|
|
HTBK
3750
DELISTED
Heritage Commerce
HTBK
| $5.76M | ﹤0.01% |
671,177
-662,071
| -50% | -$5.78M |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 332 positions and reducing 6,745 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 332 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.